- Home
- SPRY vs ERO Comparison
SPRY vs ERO Comparison
Compare SPRY & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- ERO
- Stock Information
- Founded
- SPRY 2015
- ERO 2016
- Country
- SPRY United States
- ERO Canada
- Employees
- SPRY N/A
- ERO N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- ERO
- Sector
- SPRY Health Care
- ERO
- Exchange
- SPRY Nasdaq
- ERO Nasdaq
- Market Cap
- SPRY 1.8B
- ERO 1.5B
- IPO Year
- SPRY N/A
- ERO N/A
- Fundamental
- Price
- SPRY $9.93
- ERO $16.78
- Analyst Decision
- SPRY Strong Buy
- ERO Strong Buy
- Analyst Count
- SPRY 5
- ERO 1
- Target Price
- SPRY $31.00
- ERO $19.00
- AVG Volume (30 Days)
- SPRY 3.1M
- ERO 736.2K
- Earning Date
- SPRY 11-12-2025
- ERO 11-04-2025
- Dividend Yield
- SPRY N/A
- ERO N/A
- EPS Growth
- SPRY N/A
- ERO N/A
- EPS
- SPRY N/A
- ERO 1.38
- Revenue
- SPRY $112,339,000.00
- ERO $535,974,000.00
- Revenue This Year
- SPRY N/A
- ERO $64.44
- Revenue Next Year
- SPRY $188.92
- ERO $30.74
- P/E Ratio
- SPRY N/A
- ERO $12.13
- Revenue Growth
- SPRY 22367.80
- ERO 20.59
- 52 Week Low
- SPRY $9.38
- ERO $9.30
- 52 Week High
- SPRY $18.90
- ERO $23.40
- Technical
- Relative Strength Index (RSI)
- SPRY 29.99
- ERO 69.43
- Support Level
- SPRY $9.38
- ERO $14.36
- Resistance Level
- SPRY $10.15
- ERO $17.33
- Average True Range (ATR)
- SPRY 0.63
- ERO 0.54
- MACD
- SPRY 0.03
- ERO 0.18
- Stochastic Oscillator
- SPRY 16.57
- ERO 83.89
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.